Table 2

Cataracts surgery procedures performed in Tampere University Hospital Eye Centre, 2008–2020.

2008–20202008–2012*2013–2020†
Cataract surgery procedures, n (%)56 700(100%)14 435(25%)42 265(75%)
CJE20, n (%)56 295(99%)14 289(99%)42 006(99%)
CJE15, n (%)176(0.3%)58(0.4%)118(0.3%)
CJD15, n (%)34(0.1%)13(0.1%)21(0.05%)
CJC15, n (%)40(0.1%)25(0.2%)15(0.04%)
CJD20, n (%)16(0.03%)3(0.02%)13(0.03%)
CJD30, n (%)26(0.05%)3(0.02%)23(0.05%)
CJE99, n (%)70(0.1%)22(0.2%)48(0.1%)
CJD99, n (%)28(0.05%)12(0.08%)16(0.04%)
CJC99, n (%)11(0.02%)9(0.06%)2(0.005%)
CJD40, n (%)4(0.007%)1(0.007%)3(0.007%)
  • *Preoperative antibiotic eye drops were included in prophylaxis regimen until 31 December 2012.

  • †No preoperative antibiotic eye drops were included in prophylaxis regimen since 1 January 2013.

  • CJC15, intracapsular cataract extraction with implantation of artificial lens in anterior chamber and iridectomy or iridotomy; CJC99, other intracapsular cataract operation; CJD15, extracapsular cataract extraction with implantation of artificial lens in anterior chamber and iridectomy or iridotomy; CJD20, extracapsular cataract extraction with implantation of artificial lens in posterior chamber; CJD30, pars plana lensectomy; CJD40, extracapsular cataract extraction with implantation of scleral fixed artificial lens in posterior chamber; CJD99, other extracapsular cataract operations; CJE15, phakoemulsification with implantation of artificial lens in anterior chamber and iridectomy or iridotomy; CJE20, phakoemulsification with implantation of artificial lens in posterior chamber; CJE99, other extracapsular cataract operation using phakoemulsification technique.